Acne vulgaris clinical trials

What Is Acne Vulgaris?

Acne vulgaris is one of the most common skin conditions, developing when hair follicles become clogged with oil, dead skin cells, and bacteria. It typically shows up as blackheads, whiteheads, and pimples, and in more severe cases, painful cysts and nodules on the face, chest, back, and shoulders. It develops when oil glands produce too much sebum, dead skin cells build up and block pores, and bacteria naturally present on the skin multiply in that trapped environment, triggering inflammation. Genetics, hormones, and stress can all play a role in how severe it becomes.

Moderate to severe acne vulgaris can take a real toll on confidence, relationships, and daily life, and many people never find a treatment that fully works for them. Acne vulgaris clinical trials are exploring new treatment approaches that may help reduce breakouts and visible lesions for people who haven't found relief with existing options.

Enroll Now!

STUDY

Investigating a Potential New Treatment Approach for Acne Vulgaris

This study is one of several moderate to severe acne vulgaris clinical trials currently evaluating an investigational oral treatment in people with moderate to severe acne vulgaris. The main goal is to find out how well the treatment works, how safe it is, and how well participants tolerate it over time. Researchers will closely track changes in facial lesions, monitor overall health, and record any side effects throughout the study period. The study looks at three key measures: how many participants achieve clear or almost-clear skin, how much inflammatory lesions decrease, and how much non-inflammatory lesions (like blackheads and whiteheads) decrease. Eligible participants take a once-daily oral tablet for 12 weeks, with the option to continue into an extended follow-up phase for acne vulgaris research study in Arizona.

Taking part in acne vulgaris clinical trials gives patients access to an investigational treatment, frequent check-ins with a dedicated study team, and close monitoring of their skin and overall health. It's also a way to contribute to research that could shape future treatment options for people living with acne.

Age
12 Years and Older

Location:
Arizona

Status:
Recruiting

Condition
Moderate to Severe Acne Vulgaris

What to Expect in Acne Vulgaris Clinical Trials in Arizona

Joining one of PRG's acne vulgaris clinical trials starts with a screening visit to confirm eligibility, including a review of facial lesion counts and overall health. Once enrolled, participants are randomly assigned to receive either the investigational treatment or a placebo and take their assigned tablet once daily for 12 weeks.

Throughout the study, participants return for regular visits where the study team examines the skin, tracks lesion counts, checks lab work, and reviews any changes in symptoms. Participants are encouraged to share how their skin is responding and report anything unusual along the way.

Moderate to severe acne vulgaris clinical trials like this one are closely monitored by an experienced research team that prioritizes participant safety at every step. By joining, participants play a direct role in helping researchers evaluate a new option for acne and improve care for people managing it now and in the future.

Frequently Asked
Questions


  • People age 12 and older who have been diagnosed with moderate to severe acne vulgaris, based on the number and type of facial lesions present, may be eligible. Final eligibility is confirmed during the screening visit.

  • After screening, eligible participants are randomly assigned to receive either the investigational oral treatment or a placebo, taken once daily for 12 weeks. Participants attend regular visits for skin exams, lab work, and health assessments, with the option to continue into an extended follow-up phase.

  • Participants may gain access to an investigational treatment not yet available to the public, receive close monitoring from an experienced medical team at no cost, and may be compensated for their time. So, enroll in acne vulgaris clinical trial near you and get started.